These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25809711)

  • 1. No-carrier-added labeling of the neuroprotective Ebselen with selenium-73 and selenium-75.
    Helfer A; Ermert J; Humpert S; Coenen HH
    J Labelled Comp Radiopharm; 2015 Mar; 58(3):141-5. PubMed ID: 25809711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of [75Se]5-ethoxycarbonyl-4-methyl-1,2,3-selenadiazole.
    Jalilian AR; Rowshanfarzad P; Afarideh H; Shafiee A; Sabet M; Kyoumarsi M; Raisali GR
    Appl Radiat Isot; 2004 May; 60(5):659-63. PubMed ID: 15082043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant activity of the anti-inflammatory compound ebselen: a reversible cyclization pathway via selenenic and seleninic acid intermediates.
    Sarma BK; Mugesh G
    Chemistry; 2008; 14(34):10603-14. PubMed ID: 18932179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cu-catalyzed efficient synthetic methodology for ebselen and related Se-N heterocycles.
    Balkrishna SJ; Bhakuni BS; Chopra D; Kumar S
    Org Lett; 2010 Dec; 12(23):5394-7. PubMed ID: 21053969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusually short chalcogen bonds involving organoselenium: insights into the Se-N bond cleavage mechanism of the antioxidant ebselen and analogues.
    Thomas SP; Satheeshkumar K; Mugesh G; Guru Row TN
    Chemistry; 2015 Apr; 21(18):6793-800. PubMed ID: 25766307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic studies of the radical-scavenging activity of ebselen, a seleno-organic compound.
    Fujisawa S; Kadoma Y
    Anticancer Res; 2005; 25(6B):3989-94. PubMed ID: 16309189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper(I)-catalyzed highly efficient synthesis of benzoselenazoles and benzotellurazoles.
    Fujiwara S; Asanuma Y; Shin-ike T; Kambe N
    J Org Chem; 2007 Oct; 72(21):8087-90. PubMed ID: 17867702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reaction of ebselen with peroxynitrite.
    Masumoto H; Sies H
    Chem Res Toxicol; 1996; 9(1):262-7. PubMed ID: 8924601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione peroxidase (GPx)-like antioxidant activity of the organoselenium drug ebselen: unexpected complications with thiol exchange reactions.
    Sarma BK; Mugesh G
    J Am Chem Soc; 2005 Aug; 127(32):11477-85. PubMed ID: 16089478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Density functional theory study of the attack of ebselen on a zinc-finger model.
    Antony S; Bayse CA
    Inorg Chem; 2013 Dec; 52(24):13803-5. PubMed ID: 24266546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Selenization of salicylic acid derivatives yielded isoform-specific 5-lipoxygenase inhibitors.
    Yu SC; Kuhn H; Daniliuc CG; Ivanov I; Jones PG; du Mont WW
    Org Biomol Chem; 2010 Feb; 8(4):828-34. PubMed ID: 20135040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ebselen has dehydroascorbate reductase and thioltransferase-like activities.
    Jung CH; Washburn MP; Wells WW
    Biochem Biophys Res Commun; 2002 Mar; 291(3):550-3. PubMed ID: 11855823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Density functional theory study of the reaction mechanism and energetics of the reduction of hydrogen peroxide by ebselen, ebselen diselenide, and ebselen selenol.
    Pearson JK; Boyd RJ
    J Phys Chem A; 2007 Apr; 111(16):3152-60. PubMed ID: 17407273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ebselen like catalyst with enhanced GPx activity via a selenol intermediate.
    Balkrishna SJ; Kumar S; Azad GK; Bhakuni BS; Panini P; Ahalawat N; Tomar RS; Detty MR; Kumar S
    Org Biomol Chem; 2014 Feb; 12(8):1215-9. PubMed ID: 24448734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the oxidation of ebselen and other organoselenium compounds using explicit solvent networks.
    Bayse CA; Antony S
    J Phys Chem A; 2009 May; 113(19):5780-5. PubMed ID: 19374403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ebselen, a seleno-organic antioxidant, as an electrophile.
    Sakurai T; Kanayama M; Shibata T; Itoh K; Kobayashi A; Yamamoto M; Uchida K
    Chem Res Toxicol; 2006 Sep; 19(9):1196-204. PubMed ID: 16978024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose ebselen does not afford sustained neuroprotection to rats subjected to severe focal cerebral ischemia.
    Salom JB; Pérez-Asensio FJ; Burguete MC; Marín N; Pitarch C; Torregrosa G; Romero FJ; Alborch E
    Eur J Pharmacol; 2004 Jul; 495(1):55-62. PubMed ID: 15219820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization, and antioxidant activity of some ebselen analogues.
    Bhabak KP; Mugesh G
    Chemistry; 2007; 13(16):4594-601. PubMed ID: 17299817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of substituents on the GPx-like activity of ebselen: steric versus electronic.
    Pearson JK; Boyd RJ
    J Phys Chem A; 2008 Feb; 112(5):1013-7. PubMed ID: 18197644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ebselen and Analogues: Pharmacological Properties and Synthetic Strategies for Their Preparation.
    Santi C; Scimmi C; Sancineto L
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.